Management of Patients with SARS-CoV-2 Infection
| Autor: | G A Vassallo, Giovanni Addolorato, Carmela M. Garante, Adwoa Agyei-Nkansah, Sara Rotunno, Anna Cirrincione, Giuseppe Augello, Francesco Cristiano Raimondo, Tommaso Dionisi |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) fungi Respiratory disease macromolecular substances Disease medicine.disease_cause medicine.disease Pneumonia Internal medicine medicine Mild form skin and connective tissue diseases Antipyretic drugs business Coronavirus |
| Zdroj: | In Clinical Practice ISBN: 9783030780203 |
| DOI: | 10.1007/978-3-030-78021-0_9 |
| Popis: | COVID-19 is a respiratory disease due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with SARS-CoV-2 infection can experience a range of clinical manifestations, from no symptoms to critical illness. The management and healthcare setting of this disease change according to the degree of its severity. In the mild form, patients need only symptomatic therapy, like antipyretic drugs, while in the more severe form, patients need to be hospitalized, multiparametric monitoring, prevention of complications, anti-inflammatory and antiviral drugs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|